Consort Medical plc (the Company’) is pleased to announce the appointment of Nick Higgins to the board of Consort as an Executive Director (Corporate Development Director) with effect from 1 January 2011.
Nick joined Consort as Director of Corporate Development in January 2010. He joined the Company from Intercytex Group plc where he was Chief Executive Officer from 2005 to 2009. Prior to that he was Chief Business Officer of Acambis plc, a vaccines specialist, where he worked for 11 years.Nick is currently a director of Regenerative Medicine Assets Limited (formerly Intercytex Group plc).
He currently has the following interests in Consort’s ordinary shares:
Long Term Incentive Plan 82,376
Company Share Option Plan 6, 726
Save As You Earn Option Scheme 2, 357
Share Incentive Plan (Partnership Shares)283
Consort confirms that there are no further disclosures to be made under Rule 9.6.13 of the Listing Rules.
Peter Fellner, Chairman of Consort Medical plc said: We are delighted to announce the appointment of Nick to the board.His operational and strategic knowledge of Consort and the markets in which we operate will allow him to contribute at board level to the future strategic development of the Company.
Consort Medical plc
Jonathan Glenn, Chief Executive Tel: +44 (0) 1442 867920
Toby Woolrych, Group Finance Director Tel: +44 (0) 1442 867920